Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 9 (4), 865-871
- https://doi.org/10.1016/s0735-1097(87)80243-7
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Hypertensive Hypertrophic Cardiomyopathy of the ElderlyNew England Journal of Medicine, 1985
- Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction.Circulation, 1984
- Studies on positive inotropic agents. I. Synthesis of 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenolAmerican Heart Journal, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition.Circulation, 1982
- Hemodynamic Effects of Hypovolemia in Normal Subjects and Patients with Congestive Heart FailureCirculation, 1969
- Studies on Starling's Law of the HeartCirculation, 1964
- Peripheral Venoconstriction in Human Congestive Heart FailureCirculation, 1956